Figures & data
Table 1 Baseline characteristics of study participants (n=382)
Figure 2 Prevalence of biologic, behavioral, and nonmodifiable risk factors in the study population.
![Figure 2 Prevalence of biologic, behavioral, and nonmodifiable risk factors in the study population.](/cms/asset/16a420e2-950b-4799-94c9-b305355a7e3f/dvhr_a_176167_f0002_c.jpg)
Figure 3 The awareness of various risk factors.
![Figure 3 The awareness of various risk factors.](/cms/asset/fed0a63c-109f-42a3-8b51-e15faaa44bb1/dvhr_a_176167_f0003_c.jpg)
Table 2 Awareness status of the main RFs according to the sociodemographic characteristics and other factors of the participants and presenting these RFs
Table 3 Multivariable predictors on the awareness of hypertension and obesity
Figure 4 Adherence to treatment and prevention interventions.
Abbreviations: ADD, antidiabetic drugs; AHD, antihypertensive drugs; LLD, lipid-lowering drugs; PA, physical activity.
![Figure 4 Adherence to treatment and prevention interventions.](/cms/asset/dc824351-12da-47e2-ba99-2be6b9cf2797/dvhr_a_176167_f0004_c.jpg)
Table 4 Description of healthy behaviors among different risk groups (n=382)